Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

BACKGROUND: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify prognostic tumor DNA methylation biomarkers. RESULTS: To identify gene...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Decock, Anneleen, Ongenaert, Maté, Hoebeeck, Jasmien, De Preter, Katleen, Van Peer, Gert, Van Criekinge, Wim, Ladenstein, Ruth, Schulte, Johannes H, Noguera, Rosa, Stallings, Raymond L, Van Damme, An, Laureys, Geneviève, Vermeulen, Joëlle, Van Maerken, Tom, Speleman, Frank, Vandesompele, Jo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2012
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491423/
https://ncbi.nlm.nih.gov/pubmed/23034519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gb-2012-13-10-r95
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires